As leader of ZS’s global transformation practice, Hensley helps clients pull through key strategic decisions and ensures that the organization is able to realize the intended benefits of these choices. Hensley and her team often start by creating a clear vision for the organizational transformation and building a strong business case for change.
Working with deep domain experts in R&D, go-to-market or commercialization, digital integration, tech and analytics or patient centricity, Hensley and the transformation management team create a clear roadmap for change. She designs the optimal organization, operating model and customer engagement approach to achieve key business goals. Integrating the science of applied behavioral insights into ZS’s change enablement approach and designing the experience of involved team members ensures that change is embraced and integrated.
Hensley is a strategic leader in the health and wellness industry, with special expertise in helping pharmaceutical organizations build patient-centric organizations and capabilities. She co-authored the book “Reinventing Patient Centricity,” published in 2022, and has worked with some of the world’s largest pharmaceutical companies to define patient-centric strategy. She brings a unique combination of deep analytics and data knowledge, decades of work championing the patient perspective and unstructured problem-solving to help clients develop new solutions that deliver value for their business as well as improved outcomes for patients.
Before joining ZS, Hensley was executive vice president of strategy and analytics at Saatchi & Saatchi Health and Wellness, where she led consumer and patient marketing strategy across multiple brands and therapeutic categories. She also spent eight years leading imc2’s health and wellness practice and four years as president of Harte-Hanks Direct and Interactive.
Hensley holds an MBA from the Wharton School and a B.A. in economics from Duke University.